We utilized the previously described Bz-sensitive (BzS) and Bz-resistant (BzR) mouse cells lines [10] derived from tumors of the Bcl-XL/Myc double transgenic mouse model of PC malignancy [11]–[13]. The gene discussed is BCL2L1; the disease is pachyonychia congenita.